These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The stability of human pepsins in stored gastric juice. Whitecross DP; Piper DW Scand J Gastroenterol; 1975; 10(4):395-9. PubMed ID: 239449 [TBL] [Abstract][Full Text] [Related]
5. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Pearson JP; Ward R; Allen A; Roberts NB; Taylor WH Gut; 1986 Mar; 27(3):243-8. PubMed ID: 3084340 [TBL] [Abstract][Full Text] [Related]
6. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus. Pearson JP; Roberts NB Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980 [TBL] [Abstract][Full Text] [Related]
7. Physiological study of pH stability and sensitivity to pepsin of human gastric lipase. Ville E; Carrière F; Renou C; Laugier R Digestion; 2002; 65(2):73-81. PubMed ID: 12021480 [TBL] [Abstract][Full Text] [Related]
8. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A. Roberts NB; Taylor WH J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911 [TBL] [Abstract][Full Text] [Related]
9. Pepsins and the mucus barrier in peptic ulcer disease. Allen A; Pearson JP; Blackburn A; Coan RM; Hutton DA; Mall AS Scand J Gastroenterol Suppl; 1988; 146():50-7. PubMed ID: 3147508 [TBL] [Abstract][Full Text] [Related]
10. Substrate and inhibitor studies with human gastric aspartic proteinases. Baxter A; Campbell CJ; Grinham CJ; Keane RM; Lawton BC; Pendlebury JE Biochem J; 1990 May; 267(3):665-9. PubMed ID: 2111133 [TBL] [Abstract][Full Text] [Related]
11. Effect of a pepsin-inhibitory pentapeptide upon the peptic activity and acidity of gastric secretion. Svendsen LB; Guldager N; Christensen L; Christiansen PM Scand J Gastroenterol; 1976; 11(5):459-64. PubMed ID: 785587 [TBL] [Abstract][Full Text] [Related]
12. Studies on acid protease fractions and gastric mucosal atrophy. 1. A modified simple method for separate determination of alkali labile pepsin in gastric juice by alkali treatment or by using a synthetic substrate. Yamamoto S Gastroenterol Jpn; 1980; 15(5):488-95. PubMed ID: 6777228 [TBL] [Abstract][Full Text] [Related]
13. Assay of gastricsin and individual pepsins in human gastric juice. Jones AT; Balan KK; Jenkins SA; Sutton R; Critchley M; Roberts NB J Clin Pathol; 1993 Mar; 46(3):254-8. PubMed ID: 8463419 [TBL] [Abstract][Full Text] [Related]
17. The pepsins of normal human gastric juice. Etherington DJ; Taylor WH Biochem J; 1969 Jul; 113(4):663-8. PubMed ID: 4916777 [TBL] [Abstract][Full Text] [Related]
18. The pepsins of human gastric juice. Separation by electrophoresis and chromatography; the influence of gastric disease and ambient pH. Whitecross DP; Clarke AD; Piper DW Scand J Gastroenterol; 1974 Nov; 9(8):711-7. PubMed ID: 4610714 [No Abstract] [Full Text] [Related]
19. Review article: human pepsins - their multiplicity, function and role in reflux disease. Roberts NB Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():2-9. PubMed ID: 16939427 [TBL] [Abstract][Full Text] [Related]
20. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein. Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]